Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.
Mar, 23 2025
Mar, 17 2026
Aug, 23 2025
May, 5 2025
Oct, 1 2025